The value of the parameters of the severity of chronic heart failure in the assessment of cognitive dysfunction in patients with coronary heart disease


DOI: https://dx.doi.org/10.18565/therapy.2021.3.20-27

Akimova N.S., Bugaeva O.V., Sokolov I.M., Schwartz E.Yu., Kiselev A.R.

1) V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia; 2) V.A. Almazov National Medical Research Centre of the Ministry of Healthcare of Russia, Saint Petersburg; 3) National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of Russia, Moscow
Abstract. Purpose of the study: to assess the value of the left ventricular ejection fraction (LV EF) and the functional class (FC) of chronic heart failure (CHF) as potential markers and predictors of the development of morphofunctional disorders of the central nervous system (CNS) in patients with heart failure of ischemic origin.
Material and methods. A total of 54 patients with ischemic heart disease and CHF of II–IV FC were examined. The exclusion criteria were possible diseases and conditions that could independently lead to the appearance of cognitive impairments. Doppler echocardiography, nuclear magnetic resonance imaging of the brain with the calculation of the volume and length of the right and left hippocampus, dimensions of the cerebral ventricles as well as the thickness of the gray and white matter of the cerebral cortex were performed. Cognitive functions were assessed using Wechsler’s verbal and non-verbal subtests (variants 5 and 7), Bourdon’s proof test.
Results. A significant decrease in the results of the Wechsler cognitive subtests 5 and 7, a lesser thickness of the gray matter of the parietal lobes and a smaller volume of the right hippocampus in patients with III–IV FC of CHF compared with patients with II FC of CHF were found. Lower diffusion coefficients of water molecules in the white matter of the parietal and occipital lobes and a smaller thickness of the middle pedicles of the cerebellum were also found in the group of patients with III–IV FC of CHF. Comparative analysis of changes in indicators of the state of the CNS in patients with CHF with relatively intact systolic function (EF ≥45%) and in patients with CHF with reduced systolic function did not show significant differences. Also, no significant differences were found in the study of indicators of cognitive tests and parameters of nuclear magnetic resonance imaging of the brain in patients with heart failure with EF ≤35% and EF >35%.
Conclusion. The FC of CHF, obviously, characterizes not only the severity of heart failure, but can also be considered as a marker of cognitive dysfunction, while the EF of the LV is less significant in this regard.
Keywords: chronic heart failure, cognitive dysfunction, central nervous system, ejection fraction, functional class

Literature



  1. Sepehri Shamloo A., Dagres N., Mussigbrodt A. et al. Atrial fibrillation and cognitive impairment: new insights and future directions. Heart Lung Circ. 2020; 29(1): 69–85. doi: 10.1016/j.hlc.2019.05.185.

  2. Diener H.C., Hart R.G., Koudstaal P.J. et al. Atrial fibrillation and cognitive function: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73(5): 612–19. doi: 10.1016/j.jacc.2018.10.077.

  3. Iulita M.F., Girouard H. Treating hypertension to prevent cognitive decline and dementia: Re-opening the debate. Adv Exp Med Biol. 2017; 956: 447–73. doi: 10.1007/5584_2016_98.

  4. Kapusta J., Kidawa T.M., Rynkowska-Kidawa M. et al. Evaluation of frequency of occurrence of cognitive impairment in the course of arterial hypertension in an elderly population. Psychogeriatrics. 2020; 20(4): 406–11. doi: 10.1111/psyg.12521.

  5. Cannon J.A., Moffitt P., Perez-Moreno A.C. et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail. 2017; 23(6): 464–75. doi: 10.1016/j.cardfail.2017.04.007.

  6. Остроумова О.Д., Смолярчук Е.А., Поликарпова О.А. Головной мозг как орган-мишень артериальной гипертензии. Фарматека 2010; 20: 48–53. [Ostroumova O.D., Smolyarchuk E.A., Polikarpova O.A. The brain as a target organ for arterial hypertension. Farmateka. 2010; 20: 48–53 (In Russ.)].

  7. Деревнина Е.С., Аристарин М.А., Ушаков В.Ю., Труфанова Ю.Ю. Когнитивная дисфункция при фибрилляции предсердий на фоне сердечно-сосудистой патологии. Современные проблемы науки и образования. 2015; 1–1: 1361. [Derevnina E.S., Aristarin M.A., Ushakov V.Yu., Trufanova Yu.Yu. Cognitive dysfunction in atrial fibrillation against the background of cardiovascular pathology. Sovremennie problemi nauki i obrazovaniya = Modern issues of science and education. 2015; 1–1: 1361 (In Russ.)].

  8. Kim J.H., Shah P., Tantry U.S., Gurbel P.A. Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications. Curr Heart Fail Rep. 2016; 13(6): 319–28. doi: 10.1007/s11897-016-0308-6.

  9. Pressler S.J., Jung M. Chronic heart failure with memory and attention dysfunction: old problem, thinking anew. JACC Heart Fail. 2018; 6(7): 593–95. doi: 10.1016/j.jchf.2018.04.017.

  10. Акимова Н.С., Соколов И.М., Хромых А.Ю., Мартынович Т.В. Проблема сочетанной патологии хронической сердечной недостаточности и морфофункционального состояния центральной нервной системы. Современные проблемы науки и образования 2015; 3: 158. [Akimova N.S., Sokolov I.M., Khromykh A.Yu., Martynovich T.V. The problem of concomitant pathology of chronic heart failure and morphofunctional state of the central nervous system. Sovremennie problemi nauki i obrazovaniya = Modern issues of science and education. 2015; 3: 158 (In Russ.)].

  11. Трач О.В., Акимова Н.С., Зуев В.В. с соавт. Когнитивные функции, характеристики гиппокампа и липидного профиля у пациентов с хронической сердечной недостаточностью ишемического генеза. Современные проблемы науки и образования 2019; 4: 47. [Trach O.V., Akimova N.S., Zuev V.V., Persashvili D.G., Shvarts Yu.G. Cognitive functions, characteristics of the hippocampus and lipid profile in patients with chronic heart failure of ischemic origin. Sovremennie problemi nauki i obrazovaniya. 2019; 4: 47 (In Russ.)].

  12. Шварц Ю.Г., Акимова Н.С., Мартынович Т.В. Изменения белого вещества головного мозга и когнитивных расстройств у пациентов с хронической сердечной недостаточностью и ишемической болезнью сердца. Саратовский научно-медицинский журнал. 2013; 1: 78–82. [Schwartz Yu.G., Akimova N.S., Martynovich T.V. Changes in the white matter of the brain and cognitive impairment in patients with chronic heart failure and coronary artery disease. Saratovskiy nauchno-meditsinskiy zhurnal = Saratov journal of medical scientific research. 2013; 1: 78–82 (In Russ.)].

  13. Акимова Н.С., Соколов И.М., Мартынович Т.В., Шварц Ю.Г. Морфофункциональное состояние головного мозга при хронической сердечной недостаточности. CardioСоматика. 2017; 2: 59–62. [Akimova N.S., Sokolov I.M., Martynovich T.V., Shvarts Yu.G. Morphofunctional state of the brain in chronic heart failure. CardioSomatika. 2017; 2: 59–62 (In Russ.)].

  14. Акимова Н.С., Шварц Ю.Г., Каримов Р.Н., Гафанович Е.Я. Канонический анализ в изучении взаимосвязи когнитивных нарушений и состояния белого вещества головного мозга при хронической сердечной недостаточности. Системный анализ и управление в биомедицинских системах. 2013; 1: 125–131. [Akimova N.S., Schwartz Yu.G., Karimov R.N., Gafanovich E.Ya. Canonical analysis in the study of the relationship between cognitive impairment and the state of the white matter of the brain in chronic heart failure. Sistemnii analiz i upravlenie v biomeditsinskikh sistemakh = Systems analysis and control in biomedical systems. 2013; 1: 125–131 (In Russ.)].

  15. Левашкина И.М., Серебрякова С.В., Ефимцев А.Ю. Диффузионно-тензорная МРТ – современный метод оценки микроструктурных изменений вещества головного мозга (обзор литературы). Вестник Санкт-Петербургского университета. Медицина. 2016; 4: 39–54. [Levashkina I.M., Serebryakova S.V., Efimtsev A.Yu. Diffusion tensor MRI is a modern method for assessing microstructural changes in the substance of the brain (literature review). Vestnik Sankt-Peterburgskogo universiteta. Meditsina = Bulletin of St. Petersburg University. The medicine. 2016; 4: 39–54 (In Russ.)].

  16. Mueller K., Thiel F., Beutner F. et al. Brain damage with heart failure: cardiac biomarker alterations and gray matter decline. Circ Res. 2020; 126(6): 750–64. doi: 10.1161/CIRCRESAHA.119.315813.

  17. Kumar R., Yadav S.K., Palomares J.A. et al. Reduced regional brain cortical thickness in patients with heart failure. PLoS One. 2015; 10(5): e0126595. doi: 10.1371/journal.pone.0126595.

  18. Fulop G.A., Ahire C., Csipo T. et al. Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice. Geroscience. 2019; 41(5): 575–89. doi: 10.1007/s11357-019-00110-1.

  19. Singh R.B., Hristova K., Fedacko J. et al. Chronic heart failure: a disease of the brain. Heart Fail Rev. 2019; 24(2): 301–07. doi: 10.1007/s10741-018-9747-3.


About the Autors


Natalia S. Akimova, MD, professor of Department of faculty therapy, faculty of general medicine of V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bol`shaya Kazach`ya Str. Tel.: +7 (927) 058-20-74. E-mail: astraveritas@yandex.ru. ORCID: 0000-0002-5935-2655
Oksana V. Bugaeva, assistant of Department of faculty therapy, faculty of general medicine of V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bol`shaya Kazach`ya Str. Tel.: +7 (927) 221-52-33. E-mail: link7fun@rambler.ru. ORCID: 0000-0003-1559-2830
Ivan M. Sokolov, MD, professor of Department of faculty therapy, faculty of general medicine of V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia. Address: 410012, Saratov, 112 Bol`shaya Kazach`ya Str. Tel.: +7 (927) 221-52-33. E-mail: docsim@bk.ru. ORCID: 0000-0002-9547-705Х
Elena Yu. Schwartz, 2-year resident of the Department of cardiovascular surgery of the Institute of medical education, V.A. Almazov National Medical Research Centre of the Ministry of Healthcare of Russia. Address: 197341, Saint Petersburg, 2 Akkuratova Str. E-mail: shwartz58@yandex.ru
Anton R. Kiselev, MD, associate professor, head of the Center for coordination of fundamental scientific activity, National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthcare of Russia. Address: 101990, Moscow, 10/3 Petroverigskiy Lane. E-mail: antonkis@list.ru. ORCID: 0000-0003-3967-3950


Бионика Медиа